Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

190 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Silibinin--a promising new treatment for cancer.
Cheung CW, Gibbons N, Johnson DW, Nicol DL. Cheung CW, et al. Anticancer Agents Med Chem. 2010 Mar;10(3):186-95. doi: 10.2174/1871520611009030186. Anticancer Agents Med Chem. 2010. PMID: 20015009 Review.
CD62L as a therapeutic target in chronic lymphocytic leukemia.
Burgess M, Gill D, Singhania R, Cheung C, Chambers L, Renyolds BA, Smith L, Mollee P, Saunders N, McMillan NA. Burgess M, et al. Among authors: Cheung C. Clin Cancer Res. 2013 Oct 15;19(20):5675-85. doi: 10.1158/1078-0432.CCR-13-1037. Epub 2013 Aug 15. Clin Cancer Res. 2013. PMID: 23948971
Erythropoietin protects against ischaemic acute renal injury.
Vesey DA, Cheung C, Pat B, Endre Z, Gobé G, Johnson DW. Vesey DA, et al. Among authors: Cheung C. Nephrol Dial Transplant. 2004 Feb;19(2):348-55. doi: 10.1093/ndt/gfg547. Nephrol Dial Transplant. 2004. PMID: 14736958
CCL2 and CXCL2 enhance survival of primary chronic lymphocytic leukemia cells in vitro.
Burgess M, Cheung C, Chambers L, Ravindranath K, Minhas G, Knop L, Mollee P, McMillan NA, Gill D. Burgess M, et al. Among authors: Cheung C. Leuk Lymphoma. 2012 Oct;53(10):1988-98. doi: 10.3109/10428194.2012.672735. Epub 2012 Apr 19. Leuk Lymphoma. 2012. PMID: 22397722
High serum levels of CD178 (soluble FasL) predict for inferior progression free survival in chronic lymphocytic leukemia treated with fludarabine-based chemotherapy.
Tate C, Burgess M, McMillan NA, Saunders NA, Cheung C, Gill D, Mollee P. Tate C, et al. Among authors: Cheung C. Leuk Lymphoma. 2019 Oct;60(10):2563-2567. doi: 10.1080/10428194.2019.1581936. Epub 2019 Jun 25. Leuk Lymphoma. 2019. PMID: 31237178 No abstract available.
190 results
Jump to page
Feedback